Why Companies Are Adding Menopause Benefits in 2026

MARKABLE Research Team · May 2026 · 6 min read

The demand is clear: 64% of working women say they want menopause-related benefits from their employer. The supply is not keeping up: only about 15% of large employers currently offer them. That gap is closing fast, and the companies that move first are gaining measurable advantages in retention, engagement, and employer brand.

64%

of working women want menopause-related benefits from their employer

Source: Bank of America Women and Financial Wellness survey, 2023

The trend in numbers

Menopause benefits have gone from virtually nonexistent to a recognized benefits category in just a few years:

2019: Fewer than 3% of employers offered any menopause-specific support (Mercer)
2023: 15% of large employers included menopause in their benefits strategy (Mercer Health Survey)
2025: 18% offered or were actively planning menopause benefits, with an additional 24% exploring options (Business Group on Health)
2026: Menopause benefits are now a standard consideration in benefits design discussions at Fortune 500 companies

The acceleration mirrors the trajectory of mental health benefits a decade ago: once a few market leaders adopted them, the rest of the market followed within 3-5 years.

What leading companies are offering

Menopause benefits programs vary in scope, but the most common components include:

Clinical access and coverage

Specialized provider networks: Partnerships with menopause-certified clinicians, often through telehealth platforms like Gennev or Midi Health
HRT coverage: Removing barriers to hormone therapy, including copay reductions and formulary improvements
Comprehensive coverage: Including related treatments such as cognitive behavioral therapy for insomnia, pelvic floor therapy, and dermatology consultations

Digital health and monitoring

Symptom tracking platforms: Tools that help employees monitor symptoms over time and share structured data with providers
Educational resources: On-demand learning about hormonal transitions, treatment options, and self-management strategies
Wellness monitoring: Longitudinal tracking of health markers associated with hormonal changes

Workplace culture and environment

Manager training programs: Building competence and confidence in supporting employees through hormonal transitions
Employee resource groups: Peer support communities that reduce stigma and share practical strategies
Environmental adjustments: Flexible temperature control, dress codes, and workspace modifications

Who is leading: Companies in financial services, technology, healthcare, and professional services have been early adopters. Bristol Myers Squibb, Bank of America, and Accenture are among those that have publicly discussed their menopause support programs. In the UK, organizations like Channel 4, Diageo, and AstraZeneca have been recognized for comprehensive policies.

The ROI data

The business case for menopause benefits rests on three pillars:

Retention savings

Mayo Clinic research (2023) found menopause-related productivity losses of $1,800 per affected employee per year. With up to 17% of symptomatic women considering quitting their jobs, the retention math alone justifies investment. Replacing a mid-career professional costs 6-9 months of salary, according to SHRM.

4:1

Estimated ROI of comprehensive menopause benefits programs (modeled estimate, not a direct research finding)

Source: Employer cost modeling estimate based on Mayo Clinic and SHRM data

Productivity recovery

Presenteeism, working while symptomatic, accounts for the majority of menopause-related productivity loss. Programs that provide access to effective treatment and symptom management may help employees return to full capacity faster.

Employer brand and recruitment

Survey data suggests that a significant majority of women would factor menopause support into their decision to join or stay with an employer. As the workforce ages and women hold an increasing share of senior roles, this benefit signals organizational maturity.

How to build the business case for your CHRO

If you are an HR leader, benefits director, or wellness champion trying to get buy-in, here is a framework that works:

Quantify the affected population. In most organizations, 20-25% of the workforce is female and between ages 40 and 60. That is your addressable population. For a 5,000-person company, that may be 500-625 employees.
Calculate the cost of inaction. Multiply affected employees by $1,800 (Mayo Clinic productivity loss estimate). Then estimate turnover risk: if even 5% of affected employees leave, calculate replacement costs at 6-9 months of salary.
Benchmark against peers. Request your benefits consultant's data on competitor offerings. If your competitors offer menopause benefits and you do not, that is a talent risk.
Start with a pilot. Propose a 12-month pilot program for one business unit or location. Define success metrics upfront: utilization, employee satisfaction, retention rates, and self-reported productivity.
Connect to existing strategy. Frame menopause benefits as an extension of your DEI, women's health, or workforce aging strategy. This is not a new initiative; it is a gap in existing commitments.

The one-line pitch: "We spend $X on women's health benefits but have a blind spot for the health transition that affects every woman in our workforce between ages 40 and 60, exactly when they are in their highest-impact roles."

The bottom line

Menopause benefits are following the same adoption curve as mental health benefits, fertility benefits, and parental leave expansion. The early adopters gain a competitive advantage. The followers achieve compliance. The laggards face talent loss and reputational risk.

The data, the demand, and the regulatory direction all point the same way. The question for employers is no longer whether to act, but when and how.

See what menopause wellness monitoring looks like

MARKABLE helps employers track workforce wellness through objective, longitudinal data. Understand the impact, measure the improvement.

Calculate Your ROI →

This article is for informational purposes only and does not constitute medical, legal, or financial advice. Company examples are based on publicly available information and may not reflect current programs. MARKABLE is a general wellness product for personal awareness and self-monitoring. It is not a medical device and is not intended to diagnose, treat, cure, or prevent any disease. Always consult qualified professionals for specific guidance.